by Team Small News | Sep 10, 2025 | Pharma, Sun Pharma
The US Food and Drug Administration (FDA) has flagged Sun Pharma’s Halol plant in India with an “Official Action Indicated” (OAI) status. This decision comes after the plant was found to have repeated safety breaches. The OAI status is a serious...
by Team Small News | Sep 8, 2025 | Cipla, Lupin, Mankind, Pharma, Sun Pharma
The Indian pharmaceutical companies, Sun Pharma and Lupin, are developing oral semaglutide pills to address obesity and injection aversion. Currently, leading anti-obesity drugs like Mounjaro and Wegovy are available in injectable form, limiting accessibility and...
by Team Small News | Sep 7, 2025 | Pharma, Sun Pharma
Sun Pharmaceutical Industries, a prominent pharmaceutical company, has faced a setback in its attempt to secure approval from the Central Drugs Standard Control Organisation (CDSCO) for a bioequivalence (BE) study and Phase III clinical trial waiver for its fixed-dose...
by Team Small News | Sep 5, 2025 | Pharma, Sun Pharma
Sun Pharmaceutical Industries Limited, India’s leading pharmaceutical company, has launched a large-scale digital video campaign for Prohance D Diabetes Care, a nutritional supplement designed for individuals managing diabetes. The campaign, titled “Dekhta...
by Team Small News | Sep 2, 2025 | Pharma, Sun Pharma, Torrent Pharma, Zydus
Gujarat is playing a vital role in India’s pharmaceutical industry, driven by government initiatives and investment opportunities. The state is home to major pharmaceutical companies such as Sun Pharma, Zydus Cadila, and Intas Pharmaceuticals, contributing...
by Team Small News | Aug 26, 2025 | Aurobindo Pharma, Cipla, Lupin, Pharma, Sun Pharma
The Saudi Arabia Generic Drugs Market is expected to grow significantly, reaching US$ 8.11 billion by 2033, with a Compound Annual Growth Rate (CAGR) of 8.02% from 2025 to 2033. This growth is attributed to increased healthcare needs, government efforts to reduce...